SBC
SBC Medical Group Holdings Inc
NASDAQ · Industrials · Consulting Services · US
$5.36
+3.88%Year over year
Reported trailing growth
- Revenue
- -6.9%
- EBITDA
- +15.1%
- EBIT
- +14.1%
- EPS
- +43.6%
- Free cash flow
- +734.6%
- Operating cash flow
- +985.6%
Forward estimates
Based on analyst estimates
- Revenue
- +15.3%
- EBITDA
- -7.6%
- EPS
- +7.5%
Three-year CAGR
- Revenue
- -0.1%
- EBITDA
- +42.0%
- EBIT
- +49.7%
- Net income
- +100.6%
- EPS
- +99.8%
- Free cash flow
- -3.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026